Production assistance for cellular therapies (pact)- cell processing facilities
Ended Awarded Last action
- Contract number
- HHSN26800001
- Awardee
-
University Of Miami UEI F8THLJQSAF93 Part of University Of Miami
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $650,882
Award facts
- Opportunity
-
- NHLBIECBHB201609JB Solicitation number
- Contract value 55% obligated
-
- $650,882.00 Current, with exercised options
- $1,180,889.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South Miami, FL 33146, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Exercise an Option | $134,120 | |
| Exercise an Option | $133,018 | |
| Exercise an Option | $131,951 | |
| Exercise an Option | $130,918 | |
| Other Administrative Action | $0 | |
| Original award | $120,875 |
About this award
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $1,180,889.00 firm-fixed-price delivery order contract to the University of Miami Office of Research Administration - School of Medicine Division for "Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities". This delivery order is part of a larger PACT-CPF Indefinite Delivery Contract vehicle held by the University of Miami. The contract does not have a set-aside designation, indicating it was competed in a full and open competition. The University of Miami, a private non-profit research university, will provide specialized biomedical research and clinical services to support the NHLBI's cellular therapy initiatives. This award leverages the university's expertise as a major academic medical center conducting a wide range of federally-funded health research projects.
Quick answers
Who was awarded contract HHSN26800001?
HHSN26800001 was awarded to University Of Miami by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2016.
How much is contract HHSN26800001 worth?
The government has obligated $650,882 on HHSN26800001. Its potential value, with all options, is $1,180,889.
Is contract HHSN26800001 an order under another contract?
Yes. HHSN26800001 is a delivery order under HHSN268201600012I, an indefinite delivery contract, on Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN26800001 competed?
The extent of competition for HHSN26800001 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award